Humana Inc. (NYSE: HUM) has formed a partnership with CINQCARE, a health care company that delivers care in the home and community.
“At Humana, our unwavering commitment has always been to provide high-quality care and improve health outcomes,” Julie Mascari, president of Humana Northeast regional Medicare, said in a press statement. “By combining our expertise and resources, Humana and CINQCARE hope to make significant strides in improving the health and well-being of the diverse population of Medicare Advantage members we serve in New York.”
As part of the collaboration, the companies will serve Humana’s New York Medicare Advantage members in their homes.
“Our partnership with Humana represents a pivotal moment in our ongoing dedication to deliver care that treats members like family,” Dr. Rodney Armstead, chief medical officer at CINQCARE, said in the statement. “Together, Humana and CINQCARE will work to create a positive and enduring impact on improving health, care and well-being in the homes and communities of those who need it most.”
As a company, CINQCARE delivers a variety of home-based care services, as well as virtual care. The company has made its deep commitment to Black and Brown communities a key part of its mission.
Humana’s partnership with CINQCARE is just another step in the former’s move towards increasing its home-based care capabilities.
Based in Louisville, Kentucky, Humana is one of the largest insurance companies in the U.S. The company has roughly 5.8 million MA members. Its health care services arm, CenterWell, includes pharmacy, home health care and primary care. CenterWell Home Health has more than 350 locations.
Earlier this month, Humana CFO Susan Diamond reiterated that the company was looking to create greater density in the home health market.
Diamond also detailed the connection between home-based care and the company’s future plans for value-based care.
“Today, it’s more in a traditional sense — home, DME and infusion — and where we can reduce costs and improve outcomes,” she said. “I would say, we’re doing a great job creating value through more traditional levers by network contracting, [utilization management] and some of those things. The team continues to work on the clinical innovation, which we think is the real unlock, and where there’s substantially more dollars to be generated across the enterprise. I’d say we’re still early innings. They’re still trying to figure out exactly what interventions are necessary, and how to best deploy them to really realize the value.”